Renal cell carcinoma sharply captured by imaging technology at an early stage in a hemodialysis patient: Usefulness of noninvasive monochrome superb microvascular imaging
Autor: | Atsuyuki Tokuyama, Atsushi Obata, Takahiro Obata, Hiroyuki Kadoya, Naoki Kashihara, Rie Ohsawa, Tamaki Sasaki, Hideaki Kaneto |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
renal cell carcinoma medicine.medical_treatment 030232 urology & nephrology Case Report Type 2 diabetes Case Reports 030204 cardiovascular system & hematology Malignancy urologic and male genital diseases 03 medical and health sciences 0302 clinical medicine Vascularity Renal cell carcinoma medicine Stage (cooking) hemodialysis business.industry monochrome superb microvascular imaging Hematology Blood flow ultrasonography medicine.disease Nephrology Imaging technology Radiology Hemodialysis type 2 diabetes medicine.symptom business |
Zdroj: | Hemodialysis International. International Symposium on Home Hemodialysis |
ISSN: | 1542-4758 1492-7535 |
Popis: | It has been drawing much attention that type 2 diabetes mellitus is closely associated with increased incidence of numerous cancers and their poor prognosis. Consequently, malignancy has been recently recognized as one of diabetic complications in addition to various conventional complications. Furthermore, it is well known that the prevalence of renal cell carcinoma (RCC) is drastically increased in hemodialysis (HD) patients. Therefore, screening of RCCs in HD patients is a very important and urgent issue as there are no highly sensitive tumor markers for RCCs. Monochrome superb microvascular imaging (mSMI) is a relatively new Doppler ultrasound technique and is useful especially when evaluating very slow blood flow state, because this allows for imaging microvessels with low velocity in the absence of a contrast agent. Thus, mSMI might be also useful when contrast enhancement is not obvious on CT and/or contrast‐enhanced ultrasonography using perflubutane or contrast agents are contraindicated. Moreover, it has been reported that mSMI could effectively detect vascularity of renal malignant tumor than benign renal mass in nondialysis patients. We propose that mSMI of ultrasonography could become one of the very useful methods for detecting RCCs at an early stage with high sensitivity in HD patients. |
Databáze: | OpenAIRE |
Externí odkaz: |